---
title: "癌症分型不会做？这个思路解千愁"
date: 2022-09-26T23:44:20Z
draft: ["false"]
tags: [
  "fetched",
  "生信人"
]
categories: ["Acdemic"]
---
癌症分型不会做？这个思路解千愁 by 生信人
------
<div><p><span>分子分型是准确认识复杂疾病进而构建精准医学体系的重要基石</span><span>。然而，构建具有精确性、鲁棒性及进一步可推广性的分子分型体系是众多复杂疾病面临的极大挑战。同时，分子分型的临床价值不仅在于提示具有差异疾病表型、分子基础的患者群体，针对不同特征群体筛选有效的临床干预策略也是分子分型体系构建的重要目标。</span></p><p><span><br></span></p><p><strong><span>癌症分型高分定制化思路</span></strong></p><p><strong><span>扫码占座</span></strong></p><p><img data-galleryid="" data-ratio="1" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFjMuey3JhE83ZMib2lcGobLH7QKzYcV4WNhGWQyKMcbeOl2rs65fYfRw/640?wx_fmt=png" data-type="png" data-w="264" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFjMuey3JhE83ZMib2lcGobLH7QKzYcV4WNhGWQyKMcbeOl2rs65fYfRw/640?wx_fmt=png"></p><p><br></p><p><span>去年的发表在Briefings in Bioinformatics（IF：13.994）的研究Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. </span><span>在基于机器学习方法构建亚型预测子及潜在用药策略的相关研究提供了很好的参考思路。</span></p><p><span><br></span></p><p><span><img data-ratio="0.39699074074074076" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFv0sICunfrXCZF3S5YaHTYUQI4OvSuYnicqpfHZUtYtj2MzlhD0y94Mw/640?wx_fmt=png" data-type="png" data-w="864" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFv0sICunfrXCZF3S5YaHTYUQI4OvSuYnicqpfHZUtYtj2MzlhD0y94Mw/640?wx_fmt=png"></span></p><p><span><br></span></p><p><span>该研究围绕癌细胞的干性指数（细胞的自我更新和分化潜能），探究了基于癌症干性的分子分型和应用</span><span>。一开始确认了干性指数与基本临床特征和分子特征、肿瘤免疫微环境改变模式存在显著关联；进一步，发现干性指数升高预示患者更长的OS和更差的PFS；接着仍然是常规做法，将130个干性指数相关的差异表达基因作为特征，基于无监督的一致性聚类识别干性相关的分子分型。分型在拷贝数变异负荷、TMB上存在显著差异；干性亚型具有不同的TIME和免疫基因组模式，对免疫疗法的敏感性以及对TMZ化疗的耐药性也存在不同。</span></p><p><span><br></span></p><p><span>但随后，该分型分析相比于一般的分型识别和刻画分析有一些与众不同之处：基于CMap分析，探索针对各干性亚型的潜在治疗药物。最后，基于机器学习算法构建了亚型预测子并基于独立验证集进行了验证。</span><span>这两点分析相比于一般的分型识别和特征刻画做得更深入，也挖掘出分型分析的潜在应用价值。</span></p><p><span><br></span></p><section><span>那么我们能做什么呢？生信人为你制定了个性化分析思路：</span></section><p><br></p><section data-role="title" data-tools="135编辑器" data-id="117787"><section><section><section><section><section><br></section></section><section><section hm_fix="344:553"><span>癌症分子分型体系构建及潜在用药策略分析</span></section></section><section><section><br></section></section></section></section></section></section><section data-role="paragraph"><p><br></p></section><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">1</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">初步刻画感兴趣的关键分子特征</strong></section><section><br></section></section></section></section></section></section><section><span>临床上有大量对疾病进展有影响的分子通路值得挖掘，例如cancer hallmarks。这里我们假设研究者已根据先验知识锁定要研究的分子家族或通路基因集合。</span></section><section><br></section><p><span>1、首先展示该集合在训练集中的表达热图，这里注意过滤掉在样本中表达普遍较低的基因。然后基于ssGSEA或GSVA计算样本的基因集合富集得分（与基因表达一起展示，列按照富集得分排秩）。</span><span></span></p><p><span><br></span></p><p><span><img data-ratio="0.7409470752089137" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFxG43qicgibS0bul6c4icBS9icGaLBwYyBgFribhNxsEcIpeO9GzPiah7q78w/640?wx_fmt=png" data-type="png" data-w="359" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFxG43qicgibS0bul6c4icBS9icGaLBwYyBgFribhNxsEcIpeO9GzPiah7q78w/640?wx_fmt=png"></span></p><p><span><br></span></p><section><span>2、计算富集得分与基本临床特征（例如年龄、性别、TCGA分子亚型、KPS得分、Stage等）的关联。</span><br></section><section><span><span></span></span></section><section><span><br></span></section><p><span><img data-ratio="0.4782608695652174" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFfVWuDCX6J6DFsgvTQ8xfTV2EkicONpcQxhhYJxDym4MRGgS4K5JQP2g/640?wx_fmt=png" data-type="png" data-w="529" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFfVWuDCX6J6DFsgvTQ8xfTV2EkicONpcQxhhYJxDym4MRGgS4K5JQP2g/640?wx_fmt=png"></span></p><p><br></p><p><span>3、计算富集得分与cancer hallmarks的关联，基于同样的富集得分计算方法，获得每个cancer hallmarks相关通路的活性得分，计算spearman秩相关。<br></span></p><section><span><br></span></section><section><span>基于MSigDB 获得cancer hallmarks基因集合，基于同样的富集得分计算方法计算cancer hallmarks相关通路的活性得分，计算富集得分与cancer hallmarks的关联情况，对显著关联的特征节点进行举例说明。</span></section><p><span><br></span></p><p><span>（1）以热图形式展示每个特征节点与每个hallmark的spearman相关</span><br></p><p><span><br></span></p><p><span><img data-ratio="0.8441860465116279" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFbZaj460CtMqQmxdgK0JbOYbummfmsVLS32RtnianabRuFn6G9w7GalA/640?wx_fmt=png" data-type="png" data-w="430" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFbZaj460CtMqQmxdgK0JbOYbummfmsVLS32RtnianabRuFn6G9w7GalA/640?wx_fmt=png"></span></p><p><span><br></span></p><p><span>（2）对于重点例子补充展示散点图</span></p><p><span><br></span></p><p><span><img data-ratio="0.6980728051391863" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFG4yDEeg1bHvRhxVsIctHgLQicTofmAl5s30yHqfdZCHTpWNicgbY00lw/640?wx_fmt=png" data-type="png" data-w="467" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFG4yDEeg1bHvRhxVsIctHgLQicTofmAl5s30yHqfdZCHTpWNicgbY00lw/640?wx_fmt=png"></span></p><p><span><br></span></p><section><span>4、极端富集得分与免疫微环境的关联，基于ESTIMATE计算肿瘤纯度，免疫和基质得分，计算富集得分与肿瘤纯度，免疫和基质得分的spearman秩相关。</span><span></span><br></section><section><span><br></span></section><section><span><img data-ratio="0.2705202312138728" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJ3nc4D6RlDNo3BKIUyKfcFPic75agV7aQqT3ViaX88bEUPliaiczEDfMNw/640?wx_fmt=png" data-type="png" data-w="865" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJ3nc4D6RlDNo3BKIUyKfcFPic75agV7aQqT3ViaX88bEUPliaiczEDfMNw/640?wx_fmt=png"></span></section><section><br></section><p><span>5、直接基于富集得分中值分类样本，进行log-rank检验及单因素Cox，评估该通路与患者预后的关联。若预后存在显著差异，计算富集得分高低两组的差异表达基因，并进行功能富集。</span><span></span><br></p><p><span><br></span></p><p><span><img data-ratio="0.3611111111111111" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF9S75jIwUgxGFcNFq7868HrdAwrc7TiabM8veicGxCeGEPOVSWy0RAk5Q/640?wx_fmt=png" data-type="png" data-w="864" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF9S75jIwUgxGFcNFq7868HrdAwrc7TiabM8veicGxCeGEPOVSWy0RAk5Q/640?wx_fmt=png"></span></p><p><span><br></span></p><section><span>6、观察富集得分高低两组中的基因组变异</span><span><br></span></section><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.3341543513957307" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFyuLbWLWhE8DDibaks1gaapV0SWvVA32ibYyPMQT3H0giaTfU5TN3rInxA/640?wx_fmt=png" data-type="png" data-w="1218" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFyuLbWLWhE8DDibaks1gaapV0SWvVA32ibYyPMQT3H0giaTfU5TN3rInxA/640?wx_fmt=png"><br></p><p><br></p><section data-role="paragraph"><p><br></p></section><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">2</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">构建分子分型</strong></section><section><br></section></section></section></section></section></section><section><span>1、综合感兴趣基因集合以及富集得分高低分组的差异表达基因（综合该通路本身与通路潜在影响的基因特征）进行无监督一致性聚类，确定最优分类数。</span><span></span></section><p><span><br></span></p><p><span><img data-ratio="0.5966149506346967" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJiaibDAebJ0s2cJqqV04Qs0tYupP3RxGEkYRKic1xwwg3bBl5VqfZkBfg/640?wx_fmt=png" data-type="png" data-w="709" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJiaibDAebJ0s2cJqqV04Qs0tYupP3RxGEkYRKic1xwwg3bBl5VqfZkBfg/640?wx_fmt=png"></span></p><p><span><br></span></p><p><span>2、验证分型的预后效能（log-rank检验，单因素和多因素Cox）。</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.7100238663484487" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF0LLicXVr7faq6BB2gOXb5bDgtTUZE7VJc3AGicOeXYZqqWQPZzgu7L3g/640?wx_fmt=png" data-type="png" data-w="838" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF0LLicXVr7faq6BB2gOXb5bDgtTUZE7VJc3AGicOeXYZqqWQPZzgu7L3g/640?wx_fmt=png"></p><p><br></p><p><span>3、分型的差异通路富集</span></p><p><span><br></span></p><p><img data-galleryid="" data-ratio="1.2129380053908356" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJ5IhwptSnnJafgySoRu4pC32CbIyX6TnZE5PwcwR95IEuzg8uS8TzQ/640?wx_fmt=png" data-type="png" data-w="742" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFJ5IhwptSnnJafgySoRu4pC32CbIyX6TnZE5PwcwR95IEuzg8uS8TzQ/640?wx_fmt=png"></p><p><br></p><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">3</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">系统刻画分子分型的临床特征差异</strong></section><section><br></section></section></section><section><section data-width="100%"><br></section><p><span>基于wilcox秩和检验或Fisher精确检验计算分子分型的临床特征差异。</span></p><p><span><br></span></p></section></section></section></section><section><span><img data-ratio="0.968299711815562" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFicpjJqIceXuD5IlyK5QxpxuyLKCjDHgibhaGVmY8qfr1hywjtlYbcBibA/640?wx_fmt=png" data-type="png" data-w="347" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFicpjJqIceXuD5IlyK5QxpxuyLKCjDHgibhaGVmY8qfr1hywjtlYbcBibA/640?wx_fmt=png"></span></section><section><span><br></span></section><section><span><img data-ratio="0.35491329479768785" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFMMCoImr2iaxYSzVYKR9a4E9jN9bCibgCVN4ZZyic8Wewt18icxADcJcH9A/640?wx_fmt=png" data-type="png" data-w="865" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFMMCoImr2iaxYSzVYKR9a4E9jN9bCibgCVN4ZZyic8Wewt18icxADcJcH9A/640?wx_fmt=png"></span></section><section><span><br></span></section><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">4</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">系统刻画分子分型的基因组特征差异</strong></section><section><br></section></section></section></section></section></section><section><span>识别分型之间差异的SNV以及拷贝数变异。</span></section><p><span><br></span></p><p><img data-galleryid="" data-ratio="0.9077380952380952" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFbtfvNlGRzsab29FeQztaDQMFdHbRC2TGuaKFuibbK2SagicDSHlDXNTw/640?wx_fmt=png" data-type="png" data-w="672" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFbtfvNlGRzsab29FeQztaDQMFdHbRC2TGuaKFuibbK2SagicDSHlDXNTw/640?wx_fmt=png"></p><p><br></p><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">5</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">刻画分子分型免疫微环境特征差异</strong></section><section><br></section></section></section><section><section data-width="100%"><br></section><section><span>基于ssGSEA计算28种免疫细胞（signature来自Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer， Table S1）浸润水平。计算分型之间28种免疫细胞浸润得分的差异。计算分型之间ESTIMATE免疫和基质得分差异。</span></section><section><span><br></span></section></section></section></section></section><p><span><img data-ratio="0.7824267782426778" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFr8p3SdEILDfWHFne8QESZ1FmtZy8sSLMNPnAFJ5n2WMHgqhmheDBYw/640?wx_fmt=png" data-type="png" data-w="478" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFr8p3SdEILDfWHFne8QESZ1FmtZy8sSLMNPnAFJ5n2WMHgqhmheDBYw/640?wx_fmt=png"></span></p><section data-role="paragraph"><p><br></p></section><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">6</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">探究分型用药策略</strong></section><section><br></section></section></section></section></section></section><p><span></span></p><section><span>1、计算分型特异的差异表达基因列表，基于CMap数据库(https://clue.io/)，计算化合物的富集分数，富集分数为负且P &lt; 0.05的化合物被认为是亚型潜在的治疗药物。</span></section><p><span><br></span></p><p><span><img data-ratio="0.5895833333333333" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFNg5u0jdKVPSuZWx1QlA9syVpJGOtdBN5fnWqt5hnzRZpq3YaWW1mGw/640?wx_fmt=png" data-type="png" data-w="480" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFNg5u0jdKVPSuZWx1QlA9syVpJGOtdBN5fnWqt5hnzRZpq3YaWW1mGw/640?wx_fmt=png"></span></p><p><span><br></span></p><p><span>2、基于药物基因组数据库(GDSC、CellMiner和CCLE)收集预测药物的对应的细胞系表达数据，验证构建分型时的特征基因与药物敏感性IC50值的关联。</span></p><p><span><br></span></p><p><span><img data-ratio="0.8011583011583011" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFwDtkSSwSX7OfPOzTL7F55LFXeg1SFiblwfT0wX5USiaTEO636eu3JPnw/640?wx_fmt=png" data-type="png" data-w="518" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFwDtkSSwSX7OfPOzTL7F55LFXeg1SFiblwfT0wX5USiaTEO636eu3JPnw/640?wx_fmt=png"></span></p><p><br></p><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">7</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">建立可推广的分子分型预测模型</strong></section><section><br></section></section></section><section><section data-width="100%"><br></section><p><span>1、基于least absolute shrinkage and selection operator (LASSO) regression，support vector machine (SVM), Random Forest and Boruta (RFB)以及extreme gradient boosting (XGBoost) analyses 筛选对于分型构建贡献最大的特征（这里也可以根据数据的实际情况选择两种机器学习特征筛选方法）。</span></p><p><span><br></span></p></section></section></section></section><p><span><img data-ratio="1.9233226837060702" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFN4eOKtOmQ5SOH3b59ziakhVhQwRxs9kCrAg6QOsahsbkAMbLcWAGCDA/640?wx_fmt=png" data-type="png" data-w="313" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFN4eOKtOmQ5SOH3b59ziakhVhQwRxs9kCrAg6QOsahsbkAMbLcWAGCDA/640?wx_fmt=png"></span></p><p><span><br></span></p><p><span>2、对于不同机器学习方法筛选的特征取交集，作为最终的特征集合。构建多因素Cox回归模型，作为分型的预测模型。评估在训练集中该预测模型的预后效能。</span></p><p><span><br></span></p><p><span><img data-ratio="1.9501779359430604" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFIyY1lQG8DWSlswSvOicUHrpGIWXMtBOWibQXJo8qcJDlrxqJniaEljuxQ/640?wx_fmt=png" data-type="png" data-w="281" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFIyY1lQG8DWSlswSvOicUHrpGIWXMtBOWibQXJo8qcJDlrxqJniaEljuxQ/640?wx_fmt=png"></span></p><p><span><br></span></p><section data-tools="135编辑器" data-id="117990"><section><section><section><section><strong>0</strong><strong data-original-title="" title="">8</strong></section><section><section><strong data-brushtype="text" hm_fix="224:369">验证分型体系的临床应用</strong></section><section><br></section></section></section><section><section data-width="100%"><br></section><p><span>获得独立验证集的表达谱，独立验证集也可选用免疫治疗队列，进一步阐明分型的临床应用潜能。基于打分模型预测独立验证集中每个样本所属的分子分型，基于单因素、多因素Çox 和 log-rank检验验证分型的预后效能。</span></p><p><span><br></span></p></section></section></section></section><section><span><img data-ratio="0.26134969325153373" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF97DTHuQPc9icpxnmkib8u8xsVjbfPQHtTEasvBZQs9BQqRTZd3RcdQIA/640?wx_fmt=png" data-type="png" data-w="815" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YF97DTHuQPc9icpxnmkib8u8xsVjbfPQHtTEasvBZQs9BQqRTZd3RcdQIA/640?wx_fmt=png"></span></section><section><span><br></span></section><p><img data-galleryid="" data-ratio="0.75" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFVGraXObPX6GScKfXGBwEWr7IqeFy176G5ia87wHAPJ33vYldnUj3kbg/640?wx_fmt=png" data-type="png" data-w="860" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFVGraXObPX6GScKfXGBwEWr7IqeFy176G5ia87wHAPJ33vYldnUj3kbg/640?wx_fmt=png"></p><p><br></p><section><span>思路一字不漏的都打在屏幕上了，小伙伴们记得抄作业，如果还有抄不明白的地方该反思反思了。该思路已有成熟流程，拼手速的时候到了，拼不过别人的记得扫码联系。</span></section><p><span><br></span></p><section><strong><span>癌症分型高分定制化思路</span></strong></section><section><strong><span>扫码占座</span></strong></section><p><img data-galleryid="" data-ratio="1" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFjMuey3JhE83ZMib2lcGobLH7QKzYcV4WNhGWQyKMcbeOl2rs65fYfRw/640?wx_fmt=png" data-type="png" data-w="264" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjVbMjjfdFcZlx4m3CU826YFjMuey3JhE83ZMib2lcGobLH7QKzYcV4WNhGWQyKMcbeOl2rs65fYfRw/640?wx_fmt=png"></p><p><br></p><p><br></p><section><span>参考文献</span></section><section><span>1、 Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients, Briefings in Bioinformatics, 2021；</span></section><section><span>2、 RNAactDrug: a comprehensive database of RNAs associated with drug sensitivity from multi-omics data, Briefings in Bioinformatics, 2020；</span></section><section><span><br></span></section><section><section><section><section powered-by="xiumi.us"><section><p><span><em><strong>END</strong></em></span></p></section></section><section powered-by="xiumi.us"><section><section><svg viewbox="0 0 1 1"></svg></section></section></section></section></section></section><section powered-by="xiumi.us"><section><section><span>不想错过每天的热点和技术</span></section><section><span><span>欢迎大家添加生信人为</span><span><strong>星标</strong></span><span>推荐</span></span></section><section><br></section><section><span>撰稿  ▎云栖</span></section><section><span>排版  ▎XX</span></section><section><br></section><section><br></section></section></section><section><section><section><section><section powered-by="xiumi.us"><section><section><svg viewbox="0 0 1 1"></svg></section></section></section><section powered-by="xiumi.us"><section><p><span>最新思路推荐</span></p></section></section></section></section></section></section><section powered-by="xiumi.us"><section><table width="577"><tbody><tr opera-tn-ra-comp="_$.pages:0.layers:0.comps:4.classicTable1:0" powered-by="xiumi.us"><td colspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:4.classicTable1:0.td@@0" rowspan="1" width="30.0000%"><section powered-by="xiumi.us"><section><p><strong>细胞死亡</strong></p></section></section></td><td colspan="1" rowspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:4.classicTable1:0.td@@1" width="70.0000%"><ul><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201615&amp;idx=1&amp;sn=154c456e092116f117e2dd478b05360b&amp;chksm=8b5f2720bc28ae36b5fe6679f26f02b4f4e5dbd40d131841bab2b5b2f750d9eb44755d762f0a&amp;scene=21#wechat_redirect" textvalue="继铜死亡之后新的热点已经产生，速来围观" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">铜死亡之后新的热点已经产生</a></p></section></section></li><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203180&amp;idx=2&amp;sn=1691940307ccc4cfe3697243b9cb9c4e&amp;chksm=8b5f2103bc28a81572898c7d7890acd26396c8d5ee406cca18418aa95703571b8931b7726f3a&amp;scene=21#wechat_redirect" textvalue="免疫宠儿：T细胞耗竭如何生信" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1"><span>免疫宠儿:T细胞耗竭如何生信</span></a></p></section></section></li></ul></td></tr></tbody></table></section></section><section powered-by="xiumi.us"><section><table width="577"><tbody><tr opera-tn-ra-comp="_$.pages:0.layers:0.comps:2.classicTable1:0" powered-by="xiumi.us"><td colspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:2.classicTable1:0.td@@0" rowspan="1" width="30.0000%"><section powered-by="xiumi.us"><section><p><strong>液体活检</strong></p></section></section></td><td colspan="1" rowspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:2.classicTable1:0.td@@1" width="70.0000%"><ul><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201119&amp;idx=1&amp;sn=d800875263210c6e2cd3c16705a06ef2&amp;chksm=8b5f1930bc289026ba7c8d67a799b6c989f420be59c27a2bc07b5adee5ee534f515aeca88129&amp;scene=21#wechat_redirect" textvalue="循环肿瘤细胞（CTC）纯生信" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1"><span>循环肿瘤细胞（CTC）纯生信</span></a></p></section></section></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201119&amp;idx=2&amp;sn=e89e65a89491f16645a09adb836dfedb&amp;chksm=8b5f1930bc289026884130783822038ace15df042eae07a6a2ae400a7320d024058634013d7d&amp;scene=21#wechat_redirect" textvalue="外泌体经典生信思路" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">外泌体经典生信思路</a><br></p></li></ul></td></tr></tbody></table></section></section><section powered-by="xiumi.us"><section><table width="577"><tbody><tr opera-tn-ra-comp="_$.pages:0.layers:0.comps:3.classicTable1:0" powered-by="xiumi.us"><td colspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:3.classicTable1:0.td@@0" rowspan="1" width="30.0000%"><section powered-by="xiumi.us"><section><p><strong>单细胞</strong></p></section></section></td><td colspan="1" rowspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:3.classicTable1:0.td@@1" width="70.0000%"><ul><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201367&amp;idx=2&amp;sn=fd6320cc25787ad825b08030f8c8b76e&amp;chksm=8b5f1838bc28912ea7d0c565d000270e5ecfc041d8c66c07ea8edfda31580e55b5567bb06e94&amp;scene=21#wechat_redirect" textvalue="细胞通讯热点推荐" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">细胞通讯热点推荐</a></p></section></section></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201367&amp;idx=3&amp;sn=f81bd5329ef168d5fe73aad09cbd3475&amp;chksm=8b5f1838bc28912e010356fe1c19e9b454736723eeb98a1604d2fe34ca18b175bf266f6ed3e8&amp;scene=21#wechat_redirect" textvalue="经典临床耐药性问题解决方案，带你发7+" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">经典临床耐药性问题</a><br></p></li></ul></td></tr></tbody></table></section><section><br></section><section><section powered-by="xiumi.us"><section><section powered-by="xiumi.us"><section><table width="577"><tbody><tr opera-tn-ra-comp="_$.pages:0.layers:0.comps:5.classicTable1:0" powered-by="xiumi.us"><td colspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:5.classicTable1:0.td@@0" rowspan="1" width="30.0000%"><section powered-by="xiumi.us"><section><p><strong>m6A专题</strong></p></section></section></td><td colspan="1" rowspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:5.classicTable1:0.td@@1" width="70.0000%"><ul><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651195306&amp;idx=2&amp;sn=6993c45839c8c6aab4d677588697f379&amp;chksm=8b5f00c5bc2889d390fdb7f97355c210dd5fdfa281f61d8c18aef33700938cc6dbea8c65a691&amp;scene=21#wechat_redirect" textvalue="m6A调节因子整合生信分析，硬核梳理" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">m6A调节因子整合生信分析</a><br></p></section></section></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651194302&amp;idx=2&amp;sn=667dd2729c9b0f318f8c96b61a8c1c32&amp;chksm=8b5f04d1bc288dc72998dc9aa1e4958c53548a7a28caabef95a8294d989de934f5defb2b03f9&amp;scene=21#wechat_redirect" textvalue="同样是m6A胶质瘤为何越发越高" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">m6A胶质瘤为何越发越高</a><br></p></li></ul></td></tr></tbody></table></section><section><br></section><section><table width="577"><tbody><tr opera-tn-ra-comp="_$.pages:0.layers:0.comps:1.classicTable1:0" powered-by="xiumi.us"><td colspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:1.classicTable1:0.td@@0" rowspan="1" width="30.0000%"><section powered-by="xiumi.us"><section><p><strong>临床专题</strong></p></section></section></td><td colspan="1" rowspan="1" opera-tn-ra-cell="_$.pages:0.layers:0.comps:1.classicTable1:0.td@@1" width="70.0000%"><ul><li><section powered-by="xiumi.us"><section><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651201645&amp;idx=1&amp;sn=7ab1961d76dc2e6e42beca7f1a3743d4&amp;chksm=8b5f2702bc28ae14c57f9d6a354eee1d8e4cf459197832d8f8fc4e402da887effdcedd4376d9&amp;scene=21#wechat_redirect" textvalue="中药与生物信息结合思路" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1"><span>中药与生物信息结合思路</span></a></p></section></section></li><li><p><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203630&amp;idx=1&amp;sn=7c53e78bd1b761788ea40fe6c9a944e6&amp;chksm=8b5f2f41bc28a65771f40f1d5b8ae672a1ade717685e9fe90d7f86516ed6f0a0f9a63aa875aa&amp;scene=21#wechat_redirect" textvalue="基因编辑" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="2" hasload="1">基因编辑如何结合临床？</a><br></p></li></ul></td></tr></tbody></table></section></section></section></section></section><section><br></section></section><section><span>更多生信问题咨询：18501230653（微信同号）</span></section><section><span><strong><a target="_blank" href="http://mp.weixin.qq.com/s?__biz=MzA5NjU5NjQ4MA==&amp;mid=2651203234&amp;idx=1&amp;sn=cc544e754206893b7288490ac1e62b98&amp;chksm=8b5f21cdbc28a8dbc1bc0e7a18436a1457a13c8b5308de94f47b4d39c2d40fd46dcc537e6b7d&amp;scene=21#wechat_redirect" textvalue="你已选中了添加链接的内容" linktype="text" imgurl="" imgdata="null" data-itemshowtype="0" tab="innerlink" data-linktype="1"><span data-positionback="static"><img data-galleryid="" data-ratio="0.4237037037037037" data-s="300,640" data-src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjUwgMH3SicfUibpA1XUDribR12vxxqnn7kHzY6gX7ibic1CNEctqe8KmvKMgMsbYOs35FoVo6A3g1hq3Uw/640?wx_fmt=png" data-type="png" data-w="1350" src="https://mmbiz.qpic.cn/mmbiz_png/N3X4LBoaQjUwgMH3SicfUibpA1XUDribR12vxxqnn7kHzY6gX7ibic1CNEctqe8KmvKMgMsbYOs35FoVo6A3g1hq3Uw/640?wx_fmt=png"></span></a></strong></span><span></span></section></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/ZPKVY20ecj6mpvbKmZ4sgQ",target="_blank" rel="noopener noreferrer">原文链接</a>
